Cardiac Resynchronisation Therapy In Heart Failure
Links shared publicly online about this topic.
- 0total visits
Cardiac Resynchronisation Therapy In Heart Failure
View full resource at medicalnewstoday.com
Tags: Heart, Heart Disease, Heart Failure, Clinical Trial
Most Recently Shared on December 22, 2011 at 3:13 am By:
Cardiac Resynchronisation Therapy In Heart Failure: Substantial improvements in symptoms and survival Large-sca... http://t.co/z6iTSmnK
Also Shared By:
BioCardia and Juventas Announce Phase II Development Program of JVS-100 Delivered With the Helical Infusion System to Treat Heart Failure | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: BioCardia, a leading provider of cardiovascular catheter systems designed to deliver biologic therapies for cardiac regeneration and Juventas Therapeutics, a cl...” View full resource at bioportfolio.com
Most Recently Shared on March 14, 2012 at 10:56 pm By:
BioPortfolio News BioCardia and Juventas Announce Phase II Development Program of JVS100 Deliv... http://t.co/DrOD8qoE BioPortfolio News
Cardiac Resynchronization Therapy Improved Heart Failure After Left Bundle Branch Block During Transcatheter Aortic Valve Implantation | Journal of Invasive Cardiology
invasivecardiology.com — “Cardiac Resynchronization Therapy Improved Heart Failure After Left Bundle Branch Block During Transcatheter Aortic Valve Implantation | Journal of Invasive Cardiology” View full resource at invasivecardiology.com
Most Recently Shared on March 12, 2012 at 8:09 pm By:
Cardiac resynchronization therapy used to treat LBBB developing after TAVI. http://t.co/DyQ32ykP
Heart Failure - Cardiac Resynchronization Therapy Is Effective
medicalnewstoday.com — “Heart failure continues to be the most prevalent reason for acute hospital admission, although it is stubbornly resistant to treatment. Mortality and morbidity rates remain high, despite prognosis” View full resource at medicalnewstoday.com
Most Recently Shared on January 5, 2012 at 4:05 pm By:
Heart Failure - Cardiac Resynchronization Therapy Is Effective - Medical News Today http://t.co/NvF06Z0K #medicine
FDA panel recommends CRT-D for mildy symptomatic HF patients
cardiovascularbusiness.com — “The FDA’s Circulatory Systems Devices Advisory Panel determined Dec. 7 in a three-to-two vote that the overall clinical benefits of Medtronic's cardiac resynchronization therapy with implantable cardioverter-defibrillator (CRT-D) devices outweigh the risks in treating certain mildly symptomatic heart failure (HF) patients. The recommendation, which was based on data from the RAFT and REVERSE trials, could pave the way for a potential expanded labeling approval for these devices, if the FDA choos” View full resource at cardiovascularbusiness.com
Most Recently Shared on December 8, 2011 at 4:33 pm By:
FDA panel recommends CRT-D for mildy symptomatic HF patients http://t.co/93piPQSY
Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure
news-medical.net — “Boston Scientific Corporation has enrolled the first patients in its NECTAR-HF (NEural Cardiac TherApy foR Heart Failure) clinical trial. NECTAR-HF is a prospective, randomized, international clinical feasibility study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients.” View full resource at news-medical.net
Most Recently Shared on September 30, 2011 at 5:14 am By:
Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure: Boston Scientific Corp... http://t.co/kz1NyORx
HFSA: Catheter ablation versus drug therapy for VT
cardiovascularbusiness.com — “BOSTON—Catheter ablation may have the ability to reduce the recurrence of ventricular tachycardia (VT), however, which is the best option for these arrhythmia patients: drug therapy or ablation? William G. Stevenson, MD, director of the clinical cardiac electrophysiology program at Brigham and Women’s Hospital in Boston, asked during a Sept. 19 presentation at the 15th annual Heart Failure Society of America (HFSA) scientific meeting.” View full resource at cardiovascularbusiness.com
Most Recently Shared on September 20, 2011 at 4:39 pm By:
HFSA: Catheter ablation versus drug therapy for VT - BOSTON—Catheter ablation may have the ability to reduce the rec... http://t.co/QZBFGjiw
Medical News: ESC: Mitral Clip Turns CRT Non-Responders into Responders - in Meeting Coverage, ESC from MedPage Today
medpagetoday.com — “PARIS -- Patients with severe heart failure and mitral regurgitation who are not responding to cardiac resynchronization therapy (CRT) significantly improved with a percutaneously inserted mitral valv” View full resource at medpagetoday.com
Most Recently Shared on September 16, 2011 at 8:10 pm By:
Medical News: ESC: Mitral Clip Turns CRT Non-Responders into Responders - http://t.co/3DYUp1fJ from @medpagetoday #health #medicine
Medical News: Response During CRT Implantation Predicts Benefit - in Cardiovascular, CHF from MedPage Today
medpagetoday.com — “Hemodynamic response while optimizing lead placement with pressure wire guidance predicts long-term response to cardiac resynchronization therapy (CRT), researchers found in a small study.” View full resource at medpagetoday.com
Most Recently Shared on August 31, 2011 at 6:08 pm By:
Medical News: Response During CRT Implantation Predicts Benefit - http://t.co/xVgRvIR from @medpagetoday #health #medicine
Medical News: ESC: Mitral Clip Turns CRT Non-Responders into Responders - in Meeting Coverage, ESC from MedPage Today
medpagetoday.com — “PARIS -- Patients with severe heart failure and mitral regurgitation who are not responding to cardiac resynchronization therapy (CRT) significantly improved with a percutaneously inserted mitral valv” View full resource at medpagetoday.com
Most Recently Shared on August 31, 2011 at 5:48 pm By:
Medical News: ESC: Mitral Clip Turns CRT Non- - http://t.co/ng2tkcM from @medpagetoday #health #medicine
Medical News: Response During CRT Implantation Predicts Benefit - in Cardiovascular, CHF from MedPage Today
medpagetoday.com — “Hemodynamic response while optimizing lead placement with pressure wire guidance predicts long-term response to cardiac resynchronization therapy (CRT), researchers found in a small study.” View full resource at medpagetoday.com
Most Recently Shared on August 30, 2011 at 8:53 pm By:
Response During CRT Implantation Predicts Benefit (CME/CE) http://t.co/p5ReuKR
Medical News: ESC: Mitral Clip Turns CRT Non-Responders into Responders - in Meeting Coverage, ESC from MedPage Today
medpagetoday.com — “PARIS -- Patients with severe heart failure and mitral regurgitation who are not responding to cardiac resynchronization therapy (CRT) significantly improved with a percutaneously inserted mitral valv” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 4:15 pm By:
ESC: Mitral Clip Turns CRT Non-Responders into Responders (CME/CE) http://t.co/TgDdz0t
ESC | Congresses | ESC Congress 2011 | SMART-AV: The role of electrical delay (QLV) to predict left ventricular reverse remodeling with cardiac resynchronization therapy
escardio.org — “Congress report, ESC congress 2011,Clinical Trial Update II - Rate and rhythm,Heart failure, other” View full resource at escardio.org
Most Recently Shared on August 29, 2011 at 1:50 pm By:
SMART-AV clinical trial update report http://ow.ly/6fp3C #escparis2011
Mitraclip therapy demonstrates benefits for heart failure patients who do not respond to cardiac resynchronization therapy
sciencedaily.com — “Medical researchers demonstrate that the percutaneous catheter-based MitraClip treatment improves symptoms and promotes reverse left ventricular (LV) remodeling in patients with mitral regurgitation (MR), who do not respond to cardiac resynchronization therapy (CRT).” View full resource at sciencedaily.com
Most Recently Shared on August 28, 2011 at 6:34 pm By:
Mitraclip therapy demonstrates benefits for heart failure patients who do not respond to cardiac resynchronizati... http://t.co/jk5NtLS
Implantable cardioverter defibrillators and cardiac resynchronisation therapy : The Lancet
thelancet.com — “Implantable cardioverter defibrillators and cardiac resynchronisation therapy. By - Dr Johannes Holzmeister MD, Prof Christophe Leclercq MD” View full resource at thelancet.com
Most Recently Shared on August 19, 2011 at 10:51 pm By:
Medical therapy for chronic heart failure - http://t.co/lhKSvLg and ICD/CRT - http://t.co/kZmZqsJ
Advertisement





MNT Cardiovascular
@mnt_cardiovasc
Heart Failure - Cardiac Resynchronization Therapy Is Effective http://t.co/3nBNEd6h #cardiovascular
1 year ago...